294 related articles for article (PubMed ID: 17364896)
1. Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Piccinni MN; Peros E; Geroldi D; Fogari E; D'Angelo A
Endothelium; 2007; 14(1):45-51. PubMed ID: 17364896
[TBL] [Abstract][Full Text] [Related]
2. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
Derosa G; D'Angelo A; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; Cicero AF
Heart Vessels; 2007 Nov; 22(6):361-70. PubMed ID: 18043992
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects.
Derosa G; D'Angelo A; Tinelli C; Devangelio E; Consoli A; Miccoli R; Penno G; Del Prato S; Paniga S; Cicero AF
Diabetes Metab; 2007 Apr; 33(2):129-34. PubMed ID: 17320450
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia.
Derosa G; Maffioli P; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Mereu R; Palumbo I; Randazzo S; Cicero AF
Clin Invest Med; 2009 Apr; 32(2):E124-32. PubMed ID: 19331801
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-2 and -9 levels in obese patients.
Derosa G; Ferrari I; D'Angelo A; Tinelli C; Salvadeo SA; Ciccarelli L; Piccinni MN; Gravina A; Ramondetti F; Maffioli P; Cicero AF
Endothelium; 2008; 15(4):219-24. PubMed ID: 18663625
[TBL] [Abstract][Full Text] [Related]
7. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics.
Kardeşler L; Biyikoğlu B; Cetinkalp S; Pitkala M; Sorsa T; Buduneli N
Oral Dis; 2010 Jul; 16(5):476-81. PubMed ID: 20233316
[TBL] [Abstract][Full Text] [Related]
8. Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.
Lee SW; Song KE; Shin DS; Ahn SM; Ha ES; Kim DJ; Nam MS; Lee KW
Diabetes Res Clin Pract; 2005 Aug; 69(2):175-9. PubMed ID: 16005367
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
Derosa G; D'Angelo A; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Tinelli C; Cicero AF
Endothelium; 2006; 13(3):227-31. PubMed ID: 16840178
[TBL] [Abstract][Full Text] [Related]
10. Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
Kadoglou NP; Vrabas IS; Sailer N; Kapelouzou A; Fotiadis G; Noussios G; Karayannacos PE; Angelopoulou N
Diabetes Metab; 2010 Apr; 36(2):144-51. PubMed ID: 20149706
[TBL] [Abstract][Full Text] [Related]
11. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
[TBL] [Abstract][Full Text] [Related]
12. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
[TBL] [Abstract][Full Text] [Related]
13. Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
J Clin Pharm Ther; 2006 Aug; 31(4):375-83. PubMed ID: 16882108
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes.
Maxwell PR; Timms PM; Chandran S; Gordon D
Diabet Med; 2001 Oct; 18(10):777-80. PubMed ID: 11678966
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
[TBL] [Abstract][Full Text] [Related]
16. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
[TBL] [Abstract][Full Text] [Related]
17. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
[TBL] [Abstract][Full Text] [Related]
18. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
19. Possible risk factors of carotid artery atherosclerosis in the Japanese population: a primary prevention study in non-diabetic subjects.
Okada M; Miida T; Hama H; Yata S; Sunaga T; Tsuda A; Saito H
Intern Med; 2000 May; 39(5):362-8. PubMed ID: 10830174
[TBL] [Abstract][Full Text] [Related]
20. Plasma t-PA and PAI-1 antigen concentrations in non-insulin dependent diabetic patients: implication for diabetic retinopathy.
Cho YW; Yang DH; Oh DY; Baick SH; Kim SK; Kim SJ; Hong SY
Diabetes Res Clin Pract; 1994 Jan; 22(2-3):123-8. PubMed ID: 8200293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
